Soleno Therapeutics, Inc.SLNONASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-1.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-48.29%
2024211.91%
202365.01%
2022-28.84%
2021-7.49%
202042.56%
2019126.62%
2018133.91%
2017-40.81%
201614.30%